Testing effectiveness (Phase 2)Study completedNCT02428608
What this trial is testing
Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006
Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 570
Showing 20 of 0 results